The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Bloodstream infections in critically ill patients with COVID‐19
Open accessAbstract
Background: Little is known about the incidence and risk of intensive care unit (ICU)‐acquired bloodstream infections (BSI) in critically ill patients with coronavirus disease 2019 (COVID‐19). Materials and methods: This retrospective, single‐centre study was conducted in Northern Italy. The primary study objectives were as follows: (a) to assess the incidence rate of ICU‐acquired BSI and (b) to assess the cumulative risk of developing ICU‐acquired BSI. Results: Overall, 78 critically ill patients with COVID‐19 were included in the study. Forty‐five episodes of ICU‐acquired BSI were registered in 31 patients, with an incidence rate of 47 episodes (95% confidence interval [CI] 35‐63) per 1000 patient‐days at risk. The estimated cumulative risk of developing at least one BSI episode was of almost 25% after 15 days at risk and possibly surpassing 50% after 30 days at risk. In multivariable analysis, anti‐inflammatory treatment was independently associated with the development of BSI (cause‐specific hazard ratio [csHR] 1.07 with 95% CI 0.38‐3.04 for tocilizumab, csHR 3.95 with 95% CI 1.20‐13.03 for methylprednisolone and csHR 10.69 with 95% CI 2.71‐42.17 for methylprednisolone plus tocilizumab, with no anti‐inflammatory treatment as the reference group; overall P for the dummy variable = 0.003). Conclusions: The incidence rate of BSI was high, and the cumulative risk of developing BSI increased with ICU stay. Further study will clarify if the increased risk of BSI we detected in COVID‐19 patients treated with anti‐inflammatory drugs is outweighed by the benefits of reducing any possible pro‐inflammatory dysregulation induced by SARS‐CoV‐2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Horan, T. C., Andrus, M., & Dudeck, M. A. (2008) · American Journal of Infection Control · doi:10.1016/j.ajic.2008.03.002 · Cited by 6,626
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469 · cited 1×
“All rights reserved Male gender 60 (77) Comorbidities Diabetes mellitus 14 (18) Hypertension 35 (45) Respiratory disease a 10 (13) End-stage renal disease b 0 (0) Moderate/severe liver failure c 3 (4) Solid cancer 4 (5) Hematological malignancy 1 (1) HIV infection 0 (0) Characteristics at ICU admission Hospital stay b…”
BackgroundDiagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
Kellum, J. A., Lameire, N., & for the KDIGO AKI Guideline Work Group (2013) · Critical Care · doi:10.1186/cc11454 · Cited by 2,827
Clinical Characteristics of Covid-19 in New York City
Goyal, P., Choi, J. J., Pinheiro, L. C., Schenck, E. J., Chen, R., Jabri, A., Satlin, M. J., Campion, T. R., Nahid, M., Ringel, J. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2010419 · Cited by 2,234
Contrast Medium-Induced Acute Kidney Injury
Sadat, U., Usman, A., Boyle, J. R., Hayes, P. D., & Solomon, R. J. (2015) · Cardiorenal Medicine · doi:10.1159/000430770 · Cited by 1,285
Cited by
Vascular occlusion by neutrophil extracellular traps in COVID-19
Leppkes, M., Knopf, J., Naschberger, E., Lindemann, A., Singh, J., Herrmann, I., Stürzl, M., Staats, L., Mahajan, A., Schauer, C., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102925 · Cited by 446
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
Grasselli, G., Scaravilli, V., Mangioni, D., Scudeller, L., Alagna, L., Bartoletti, M., Bellani, G., Biagioni, E., Bonfanti, P., Bottino, N., et al. (2021) · Chest · doi:10.1016/j.chest.2021.04.002 · Cited by 374
Bardi, T., Pintado, V., Gomez-Rojo, M., Escudero-Sanchez, R., Azzam Lopez, A., Diez-Remesal, Y., Martinez Castro, N., Ruiz-Garbajosa, P., & Pestaña, D. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04142-w · Cited by 331
Machado, M., Estévez, A., Sánchez-Carrillo, C., Guinea, J., Escribano, P., Alonso, R., Valerio, M., Padilla, B., Bouza, E., & Muñoz, P. (2022) · Journal of Fungi · doi:10.3390/jof8030305 · Cited by 53
Drakos, P., Volteas, P., Cleri, N. A., Alkadaa, L. N., Asencio, A. A., Oganov, A., Pryor, A., Talamini, M., Rubano, J., Bannazadeh, M., et al. (2022) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-021-05015-z · Cited by 33
Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change?
Sopirala, M. M. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000736 · Cited by 8
Metadata
- Authors
- Giacobbe, D. R., Battaglini, D., Ball, L., Brunetti, I., Bruzzone, B., Codda, G., Crea, F., De Maria, A., Dentone, C., Di Biagio, A., Icardi, G., Magnasco, L., Marchese, A., Mikulska, M., Orsi, A., Patroniti, N., Robba, C., Signori, A., Taramasso, L., Vena, A., Pelosi, P., & Bassetti, M.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2020-08-11
- Volume
- 50
- Issue
- 10
- Pages
- e13319-e13319
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W3034530833
- Cited by
- 302
- References
- 26
- FWCI
- 34.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.